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Abstract: In this study, the Ficus deltoidea extract loaded nanostructured lipid carrier was prepared
by using the melt emulsification homogenization method. Virgin coconut oil is used as liquid lipid,
while glyceryl monostearate is the solid lipid. Particle size, zeta potential, entrapment efficiency, drug
loading and morphology of the obtained nanostructured lipid carrier (NLC) were measured. The size
of the nanostructured lipid carrier incorporated with Ficus deltoidea (FDNLC) is 158.0 ± 1.3 nm, with a
polydispersity index of 0.15 ± 0.02. The zeta potential obtained is −42.3 ± 1.5 mV. The encapsulation
efficiency and active ingredient loading capacity for FDNLC is 87.4% ± 1.3% and 8.5% ± 1.2%,
respectively. The shape of FDNLC is almost spherical and the stability assessment showed that
the obtained formulation is at least stable for 40 days. When compared with the positive controls,
which are Trolox and ascorbic acid, FDNLC shows the highest antioxidant value. Cell proliferation
activity study indicates that FDNLC is not toxic to cells, and FDNLC could potentially treat damage
by ultraviolet B (UVB) irradiation.
Keywords: nanostructured lipid carrier (NLC); Ficus deltoidea; virgin coconut oil; characterization;
stability; antioxidant
1. Introduction
Ficus deltoidea (FD) or better known as mistletoe fig is a small plant originated from the Moraceae
family. FD is a native plant of Malaysia that possesses potential for varied purposes. It had been used
as a traditional remedy for many diseases, including diabetes and relieving pain. Ramamurthy (2014)
reported that FD is also used for skin diseases, pneumonia, diarrhea, heart problems and migraines.
The active compounds in the extract of the plant possess anticancer, anti-inflammatory, antioxidant,
antinociceptive and antiphotoaging effects [1]. Haron stated that polyphenols and naringin are among
the chemicals found in FD, which are beneficial for anti-inflammatory effects [2].
Due to their advantages, a variety of research was executed on the application of FD. Along with
that, a study by Hasham et al. proposed that FD extract hinders the production of inflammatory
cytokines and could be an effective protection tool to treat skin diseases [3]. The research concluded
that FD extract might be helpful against ultraviolet B (UVB) induced skin damage and is beneficial in
antiphotoaging cosmetic products. UVB rays are accountable for sunburn and skin cancers such as
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malignant melanoma. Moreover, a study by Mahmood and Khaled showed an enhancement in wound
healing in rats treated with FD [4]. The results had proved the efficacy of FD extract to accelerate the
rate of wound healing in the experimentally induced wounds in rats. However, the disadvantage of
using plant extract is that the bioactive substances are unstable when exposed to light and could lose
activity during storage [5]. It is also difficult for biologically active water-soluble extracts to permeate
through human skin, which naturally has a hydrophobic attribute.
Due to the above reasons, new systems have been studied to heighten the penetration of
therapeutic molecules through the skin [6]. In the early 1990s, Solid lipid nanoparticles (SLNs) were
introduced to replace carrier systems such as emulsions, liposomes and polymeric nanoparticles [7].
However, some problems were associated with SLN, such as low drug loading and drug expulsion
that might happen during storage [8]. A nanostructured lipid carrier system (NLC) is a new generation
of SLN, which composes of a liquid lipid blended with a solid lipid to form a matrix of nanostructured
solid particle. Liquid lipid in NLC is employed to change the formation of SLN. This structure
intensifies the loading and incorporates the drug securely during storage. However, there is limited
research on the association of lipid nanocarriers with plant medicine in the bionanotechnology field [9].
Usage of appropriate renewable vegetable sources is highly feasible to comply with both industrial
and customer demands, because of the health advantages and improved delivery features it offers.
Final solid lipid core should contain structural imperfections to increase the incorporation of the drugs
into the system. The system has been manifested as an effective system to increase skin hydration
due to its physiological lipid composition and occlusive effect properties [10]. The small size of NLCs
ensures close contact with the stratum corneum and can increase the amount of the active compound
penetrating the skin [11]. NLCs are novel drug delivery systems for the delivery of actives with high
solubility, stability, powerful skin penetration, and low skin discomfort [12].
Virgin coconut oil (VCO) is described as the yield of oil coming from the fresh and mature kernel
of the coconut (Cocos nucifera L.) through mechanical and natural means, as long as it does not result in
any changes to the oil [13], whether or not using heat. Currently, VCO became very widely known for
its usefulness. In 2009, Marina et al. had proven refined coconut oil has lower antioxidant activity than
VCO [14]. Besides, VCO is an exceptional ingredient that could work as skin softener and moisturizer,
which are very important in the cosmetics industry [15]. Kim et al. had shown that VCO contributes to
protective barrier functions as the stratum corneum increased expression of cornified envelopes (CEs)
components after application of the oil [16]. In this work, VCO has been chosen as the liquid lipid in
the NLC system because of their advantages for the skin and the NLC system itself.
In this work, attempts to produce nanostructured lipid carrier incorporated with Ficus deltoidea
(FDNLC) were done using the ultrasonication technique. The successfully obtained formulation
was further characterized using several essential parameters such as particle size and polydispersity
index, zeta potential, drug entrapment efficiency (EE) and transmission electron microscopy (TEM).
The stability, antioxidant, skin permeation and cell proliferation activity were also assessed.
2. Materials and Methods
2.1. Materials
Distilled water, Ficus deltoidea extract, Folin–Ciocalteau reagent, gallic acid,
glyceryl monostearate, virgin coconut oil, Sephadex G-50, sodium carbonate, soy lecithin,
tween 80, 2,2-diphenyl-1-picrylhydrazyl (DPPH) reagent, Trolox and ascorbic acid. Fibroblast cell was
utilized throughout this experiment. Fibroblast cell (HSF 1184) was cultivated in Dulbecco’s modified
Eagle’s medium (DMEM), which contains 10% fetal bovine serum and 1% penicillin with streptomycin.
The cells were maintained at 37 ◦C in a humidified atmosphere of 5% carbon dioxide (CO2).
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2.2. Methods
2.2.1. Preparation of FD Loaded Nanostructured Lipid Carrier
Nanostructured lipid carrier incorporated with Ficus deltoidea extract (FDNLC) was prepared
using a method by Rosli et al. with minor modifications [17]. The melt emulsification homogenization
technique was used to prepare FDNLC. There were two phases involved in the preparation: the lipid
phase and aqueous phase. In this technique, both phases were prepared separately. Lipid phase
composes of solid lipid (glyceryl monostearate) and liquid lipid (virgin coconut oil). The aqueous
phase consists of distilled water, surfactant (tween-80 and soy lecithin) and also FD extract. First, soy
lecithin (6.5%) and tween-80 (7.5%) were diluted with distilled water. The mixture was heated at 40 ◦C
until all components were mixed well. For the lipid phase, 2% glyceryl monostearate was combined
with 10% VCO, and the mixture was heated until it is entirely melted. After that, the aqueous phase
mixture was added into the lipid phase mixture and then it was well stirred. A magnetic stirrer was
used to stir both mixtures. Then, the active ingredient (4% FD extract) was added to the resultant
mixture of the aqueous and lipid phases. Later, the final mixture was homogenized using IKA Ultra
Turrax® Homogenizer at 8000 rpm for three minutes. Finally, probe sonicator was used to ultrasonicate
the obtained pre-emulsion for 20 min and cooled in an iced water bath for homogenous dispersion.
2.2.2. Characterization FD Loaded Nanostructured Lipid Carrier
Measurement of Particle Size and Polydispersity Index
The particle size determination and polydispersity index (PDI) of the FDNLC sample were analyzed
by photon correlation spectroscopy using Zetasizer Nano S (Malvern Instruments, Malvern, UK).
All samples were first diluted using distilled water at a ratio of 1:9 to ensure that the light scattering
intensity was within the instrument’s sensitivity range [18]. Each of the measurement was done in
triplicate. Refractive indices for particles were 1.54, and for water was 1.33.
Encapsulation Efficiency and Drug Loading
Encapsulation efficiency (EE%) is the estimation of the quantity of encapsulated drug per unit
weight of nanoparticles. EE (%) was calculated to determine the percentage of FDNLC using
the size exclusion spin mini-column, according to Dangi and Shakya, with modifications [19].
Encapsulated NLC was separated from non-encapsulated FD extract using a spin mini-column
packed with Sephadex G-50 (Sigma Aldrich, Selangor, Malaysia) according to the size exclusion
concept. Before the spin mini-column was ready to be used, the spin mini-column was centrifuged
2000 rpm for two minutes to remove excess water. After that, 0.1 mL of NLC dispersion was loaded
into the spin mini-column without breaking the initial state of the Sephadex G-50 in the mini-column.
The mini-column was centrifuged again at 2000 rpm for 2 min to elute the encapsulated NLC,
assuming that the NLC particles were the biggest particle in the dispersion. The eluted sample in a
1.5 mL centrifuge tube was then added with ethanol (1:1 ratio) to disrupt the lipid matrix of NLC
and release the encapsulated FD extract. The same lipid disruption method was applied for the total
amount of FD extract determination. The total amount of FD extract content in the NLC dispersion
was then the sum of the encapsulated FD and the free FD extract. The validation for spin mini-column
methodology was carried out by loading the FD extract solution into the spin mini-column to prove
that the free FD extract was retained in the packed Sephadex G-50. The elution was collected and then,
the absorbance of the elution is determined by UV spectrophotometer at 760 nm. The experiments
were performed in triplicate. The encapsulation efficiency (EE%) is computed using Equation (1):
EE (%) = (n1/n2) × 100 (1)
where n1 = amount of encapsulated FD and n2 = total amount of FD in total suspension.
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While the percentage of drug loading (DL%) capacity is calculated using Equation (2):
DL (%) = [(n1 − n2)/Tlipid] × 100 (2)
where n1 = amount of encapsulated FD; n2 = total amount of FD in full suspension and
Tlipid = total weight of lipid in the formulation.
Determination of Zeta Potential
To measure the stability of the particle, the zeta potentials of the samples were measured using
Zetasizer Nano Z (Malvern Instrument, Malvern, UK). The samples were diluted with distilled water
before the analysis, and all measurements were performed at 25 ◦C. Zeta potential values of ±30 mV
and above were characterized as stable formulation. Each reading was taken in triplicate. The refractive
indices of particles and water used were 1.54 and 1.33, respectively.
Investigation of the Morphological Structure
The morphology of the FDNLC was observed through a transmission electron microscope (JEM
2100 TEM) as described by Noor et al. [20]. The freshly prepared sample was placed on copper grids
for viewing, and excess droplets were absorbed away with filter paper. After five minutes, a drop
of 2% phosphotungstic acid was placed onto the copper for staining. The grid was dried at room
temperature and observed using TEM. Multiple resolutions were used to observe the NLC image,
starting from 5 to 100 kV.
2.2.3. Stability Study
The FDNLC was stored at three different temperatures, cold (4 ◦C), room (25 ◦C) and hot (40 ◦C)
for 40 days. The size and polydispersity index of the samples were evaluated on days 1, 7, 18 and 40.
2.2.4. Antioxidant Activity
To assess the antioxidant activity, 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay was used, as
described by Sharma and Bhat [21]. Briefly, 300 µL of NLC suspension (15.625, 31.25, 62.5, 125
and 250 µg/mL) were mixed with 2.7 mL of DPPH (final concentration of DPPH was 2.0 × 10−4 M).
The mixture was vigorously shaken to ensure the samples and DPPH reagent was adequately mixed.
Then, samples were incubated at room temperature for 30 min, and the absorbance was recorded.
Mean average values were taken as the experiment was performed in triplicates. Standards that were
ascorbic acid and Trolox were used to compare the results obtained. The absorbance of DPPH was
recorded, and IC50 was calculated using Equation (3).
IC50 = [(A0−Ae)/A0] × 100 (3)
where Ae is the absorbance of the extracts. The antioxidant potential of all the extracts at each
concentration was calculated.
2.2.5. Skin Permeation Study
The diffusion experiment was conducted using Franz diffusion cells as described by Noor et al. [20].
The diffusion experiment was conducted in an automatic transdermal diffusion system (Perkin Elmer,
Norwalk, CT, USA). The cells consist of three vertical Franz style diffusion cells, a thermally controlled
circulating water bath and magnetic stir console, providing a similar condition to human skin.
An epidermis layer was installed in a specific position where the stratum corneum facing the
donor cell and the dermis layer was soaked in the receptor buffered solution. The receptor and
donor compartments were filled with PBS buffer (pH 6.5). The diffusion cells were maintained and
equilibrated at 37 ◦C by the recirculating water bath, while continuous stirring of the buffer solution
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in the receptor and the donor compartment was maintained at 300 rpm for 30 min. After 30 min of
equilibration, 1 mL of sample was added in the donor compartment. From the receptor chamber, 1 mL
aliquot of the sample was collected at 0.5, 1, 1.5, 2, 3, 4, 6, 8, 12, 16, 20 and 24 h(s). Fresh buffer at
the same amount of the collected aliquots was added to the receptor chamber to maintain a constant
volume inside the chamber. The experiment was done in triplicate. The collected receptor fluid
was evaluated using the total phenolic compound (TPC) assay to quantify the FD amount in the
samples expressed in gallic acid equivalent (GAE) and performed in duplicate. Permeated cumulative
amount of active ingredients was calculated based on the measured FD amount in GAE of the collected
receptor fluid obtained from the TPC assay in each diffusion cell and was plotted as a function of time.
From the plotted graph, the slope and the x-intercept (lag times, tL) were determined to obtain the
steady-state flux (Jss) using the linear regression analysis, following Fick’s first law. Collected samples
from in vitro skin permeation study were quantified using the total phenolic content assay representing
the amount of FD extract permeated through the skin. This method was referred from Almey et al. [22].
The quantified FD extract was expressed in gallic acid equivalent (GAE) unit. Of sample 0.1 mL was
added to 0.75 mL of 10-fold dilution of Folin–Ciocalteu reagent with vigorous mixing and was rested
for 5 min. Then, 0.75 mL of 6% (w/v) sodium carbonate was added to the solution. The samples were
incubated for 90 min at room temperature before the absorbance reading was taken at 725 nm with the
UV spectrophotometer. The measurement was performed in triplicate.
2.2.6. Cell Proliferative Study
MTT assay was used to estimate cell viability and proliferation. First, fibroblast cells were seed at
a density of 1 × 104 cells using a 96 well plate. Then, after it reached 100% confluent in culture media,
the fibroblast cells were treated with several different concentrations of FDNLC for 24 h. The media
was removed and washed with PBS. The cells were incubated in the dark with 20 µL of 5 mg/mL MTT
solution for 4 h at 37 ◦C. A volume of 100 µL of dimethyl sulfoxide (DMSO) was added to each well.
The absorbance was measured at 570 nm using TECAN M200 Pro Multiplate reader. The percentage of
the viable cells was calculated by defining the cell viability without treatment as 100%.
3. Results and Discussions
3.1. Physicochemical Properties
The FDNLC dispersions were yellowish-white in color, odorless and liquid in nature, which can
be seen in Figure 1. It was stable and did not show any sedimentation even after centrifugation at
5000 rpm for 30 min. The blank dispersions of NLC were also prepared. The blank had the same
components as FDNLC except for the amount of FD was replaced with water. The characteristics were
similar to FDNLC, but the color was whiter as it did not contain FD extract.
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Figure 1. (a) Nanostructured lipid carrier incorporated with Ficus deltoidea (FDNLC) and (b) blank
dispersions of nanostructured lipid carrier (without Ficus deltoidea).
3.2. Characterization of Ficus deltoidea Loaded Nanostructured Lipid Carrier
3.2.1. Particle Size and PDI of Ficus deltoidea Loaded Nanostructured Lipid Carrier
Initially, blank NLC dispersion and FDNLC were prepared and characterized. The most important
characteristic of an NLC formulation is the particle size. This is because the small size of nanoparticles
ensures close contact of the extract with the stratum corneum and eventually makes it easier for the
extract to penetrate the skin. Based on Table 1, the sizes are 153.1 ± 2.5 nm and 158.0 ± 1.3 nm for blank
NLC and FDNLC, respectively. The formulation for FDNLC achieved an appropriate size for the topical
route, which is less than 500 nm. The small size of NLC gives a large surface area of the system and low
interfacial tension of the droplets, thus enables easy penetration through the skin [23]. The particle size
of lipid nanoparticles is affected by various parameters, such as the composition of the formulation
and production methods. In this study, the small particle size might be owing to the surfactant
mixture, other than accurate production methods and experimental conditions. Using a blend of
emulsifiers can stabilize the emulsion in terms of the coalescence rate. When the amount of surfactant
increased, the particle size decreased with a monodispersed size distribution. This happened because
increasing the surfactant concentration lowered the surface tension and stabilized newly developed
surfaces during homogenization and produce smaller particles [24]. At decreased concentrations
of surfactant, aggregation accelerated where the coated fraction of particle surface area remained
small. This is observed in a similar study by Zirak and Pezeshki, which shows with a higher
concentration of surfactant, the particle size is smaller [24]. The amount of active ingredient, which is
FD, impacts the particle size and PDI of FDNLC. As shown in Figure 2, the size and PDI increase
steadily when the amount of FD increased in the formulation. A similar trend is observed in a study
by Das et al. [25]. The results portrayed particle size increases when active ingredient concentration
increases. Huge augmentation of particle size and PDI must be due to the presence of a large number
of unencapsulated drug molecules.
Table 1. Comparison of particle size and polydispersity index (PDI) between FDNLC and the blank.
Each value represents the mean ± SD (n = 3).
Blank FDNLC
Size (nm) 153.1 ± 2.5 158.0 ± 1.3
PDI 0.19 ± 0.01 * 0.15 ± 0.02
* p < 0.05 as compared to FDNLC, indicate as a statistically significant value.
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Figure 2. Effect of the composition of active (FD) on size and PDI of FDNLC. Experiments were done
in triplicate (n = 3).
Size, however, rarely presented as a single value but rather a representative value of a distribution
that can be narrow, moderate or broad. As can be seen in the PDI value in Table 1, there was no
significant difference between the blank and FDNLC. Both readings were below 0.2 and indicate
homogeneity of the formulations. This might be due to the sufficient power of the probe sonicator
and the time taken to homogenize the formulations. The presence of high surfactant concentrations
might also contribute to the small PDI value. High tween 80 and soy lecithin concentrations allow
ease of dispersion, reduced aggregation and hence a reduction in PDI. As reported by Mitri et al.
in 2011, the polydispersity parameter provides important indications concerning sample homogeneity,
as values below 0.25 reflect relatively homogeneous nanoparticles, with a minimum predisposition to
aggregation [26].
3.2.2. Zeta Potential of FD Loaded Nanostructured Lipid Carrier
Zeta potential is an important parameter that predicts the physical stability of colloidal dispersions.
In theory, a higher value of zeta potential, either positive or negative, tended to stabilize the suspension.
Aggregation phenomena are less likely to occur for charged particles with pronounced zeta potential
(>|30| mV) due to the electrostatic repulsion betwee particles with the same electrical charge [27].
I this study, both blank and FDNLC dispersions possessed zeta potential value higher than 30 mV,
which were −42.6 ± 1.7 mV for the blank and −42.3 ± 1.5 mV for FDNLC. This strongly suggests a good
physical stability for the formulations. It is also a sign of good skin permeation ability and long-term
durability, which is supported by the stability testing in Section 3.3. Overall, the formulations exhibit a
goo physical stability, which might be attributed to the role of surfactant.
3.2.3. Acti e Ingredient Loading and Encapsulation Efficiency of FD Loaded Nanostructured
Lipid Carrier
Active ingredient loading and encapsulation efficiency were determined by measuring the amount
of encapsulated active ingredient within the nanoparticles [25]. The encapsulation efficiency and active
ingredient loading capacity for FDNLC was 87.4% ± 1.3% an 8.5% ± 1.2%, respectively. The active
ingredient loading capacity was ≤10%, which is higher than a study by Jia et al. [28], which use
silybin as the drug, but lower than Chu et al. [29] work, which incorporated polymer in their study.
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The low value of drug loading might be due to the hydrophilic character of the FD. However, the
drug loading capacity was not very small because the presence of biocompatible surfactants in NLC
formulation facilitated the encapsulation of FD extract in FDNLC. The encapsulation efficiency was
relatively high as the amount of FD added was adequate for the encapsulation capacity of the amount
of lipid used (low drug to lipid ratio). It was reported by Jenning et al. that the incorporation of liquid
lipid to solid lipid can lead to massive crystal order disturbance, and the resulting matrix of lipid
particles indicates great imperfections in the crystal lattice and leaves enough space to accommodate
drug molecules, thus leading to improved drug entrapment efficiency and drug loading capacity [30].
High encapsulation efficiency of the formulation is beneficial to reduce the skin irritation of drug due
to avoidance of direct contact between active ingredient and skin surface.
3.2.4. Investigation of Morphological Structure
Information on the morphology and size of the particles were obtained through TEM. TEM is
actually similar to a normal microscope, but TEM used electrons instead of photons, which produce
better magnification and a clearer image. This is because electron wavelengths are smaller than light
wavelengths. Based on Figure 3, the FDNLC had a spherical shape with smooth surfaces, which is
agreeable with some other studies. In addition, the image also had confirmed the nano size of FDNLC,
which supports the results of particle size measurement by Zetasizer in Section 3.3. The uniformity of
the particle size also supports the narrow particle size distribution. Furthermore, Figure 3 depicts that
all particles were almost similar in size in each system and did not aggregate, which indicates that all
the systems were monodispersed.
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3.3. Stability of FD Loaded Nanostructured Lipid Carrier
Stability tests are important in helping to predict the shelf life of the product. The data obtained
indicate a constant value of particle size and PDI after 40 days. No flocculation, aggregation, gelation and
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color change were observed in the samples during the storage. In Figure 4, only a slight increase in
particle size was observed when the sample was stored at 40 ◦C. At room temperature, there was
a negligible decreasing trend in particle size. While at 4 ◦C, the particle size decreased from
158.0 ± 1.2 to 130.9 ± 1.5 nm. However, even after storage of 40 days, the sample stayed as nano size.
The polydispersity index (PDI) was used as a measure of broadness of molecular weight distribution.
For the PDI value, it can be seen in Figure 5, that all the samples showed an increasing trend.
However, even at day 40, the PDI value remained below 0.200. This shows a narrow particle distribution
of the samples. These results were in agreement with the zeta potential results. Venkateswarlu and
Manjunath disclosed that good stability might be derived from the small particle size, the slow
transition of lipid and the steric effect of tween 80 [31]. The particle size stability might be attributed to
the type of liquid lipid and solid lipid. Glycerol monostearate is the ester of fatty acids and glycerol,
which contain an aliphatic lipophilic chain contributed by fatty acyl group and two hydroxyl groups
form the hydrophilic part contributed by glycerol. Due to the amphiphilic nature, monoglycerides
are capable of stabilizing emulsions. The amphiphilic nature of glycerol monostearate might affect its
chemical reaction with the liquid lipid, and the hydrophilic FD extract, which would stabilize NLC
dispersion. The concentration of the surfactant also plays an important role in the stabilization of the
lipid particles of NLCs. From the concentration aspect, Huang et al. [32] demonstrated that colloidal
nanoparticles have large surface areas. When the amount of surfactant is not enough, there will be
lipid particles in NLCs being uncovered by the surfactant, leading to flocculation, aggregation and
gelation. From the stability results, it can be concluded that the amounts of tween-80 and soy lecithin
were adequate to stabilize the FDNLC. Apart from that, the blend of surfactants played an important
role in stabilizing the formulations.
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3.4. Antioxidant Activi y of FD Loaded Nanostruct i id Ca rier
DPPH assay is one of the most preferable antioxidant tests because it is rather simple and has
high sensitivity. The effect of antioxidants on DPPH is based on their hydrogen-donating ability.
When hydrogen atoms accept an unpaired electron of DPPH from antioxidants, DPPH is reduced
to yield DPPH-H, resulting in a change in the absorbance spectrum [33]. The scavenging activity
of various concentrations of FDNLC and control (Trolox and ascorbic acid) on DPPH radicals was
performed. The ability of FDNLC to reduce DPPH radicals was determined by UV absorbance at
517 nm. Okonogi et al. explained IC50 as the concentration of tested samples needed for scavenging
DPPH radical in the solution by 50% [34]. The lower the IC50 value, the stronger the antioxidant
activity of the sample. The IC50 value is extrapolated from Figure 6. Table 2 shows that FDNLC had
higher antioxidant activity as its IC50 value was 45.41 µg/mL compared to the FD extract (92.2 µg/mL),
Trolox (62.9 µg/mL) and ascorbic acid (180.0 µg/mL). This implies only 45.41 µg/mL of FDNLC is needed
to reduce the DPPH radicals compared to the standards. The high antioxidant activity of the FDNLC
might be associated with the components of the FD extract. Moreover, it could be due to the presence
of multiple hydroxyl groups in the structure of vitexin and isovitexin, the biomarker for FD extract.
However, FDNLC had higher antioxidant activity than the FD extract, which might be due to the
increased bioavailability of active in FDNLC. Increased bioavailability maximizes the active ingredient
concentration at the site of action within the skin with, ideally, a minimal systemic uptake. This result
might also be caused by the presence of VCO in FDNLC dispersions. The polyphenol compound
in VCO reduces the DPPH radicals. The total antioxidant activity of the mixtures of polyphenolic
compounds is not a simple addition of each polyphenol compound. In this study, usage of VCO
as a liquid lipid not only improves the penetration ability of FD but also facilitate in increasing the
antioxidant activity. In Figure 6, it was proven that all samples and control did have the free radical
scavenging activity. This is because the DPPH inhibition was high at a low concentration of samples
and standards. When the concentration of FDNLC increased from 15.625 to 250 µg/mL, the scavenging
activity also increased. This is due to the higher concentration of FDNLC that contained a larger
number of hydroxyl groups, which are related to their hydrogen-donating ability. The results proved
that the FDNLC had the highest antioxidant potential compared to the control, which is Trolox and
ascorbic acid, and also the FD extract.
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The experiment was done in triplicate (n = 3).
Table 2. IC50 value of FDNLC sample, FD extract and standards used in the DPPH assay.
Sample/Standard IC50 Value (µg/mL) Equation R2 Value
FDNLC 45.41 y = 15.694ln(x) − 9.8861 R2 = 0.9516
FD extract 92.20 y = 21.075ln(x) − 45.628 R2 = 0.9924
Trolox 62.90 y = 11.967ln(x) + 0.4327 R2 = 0.8024
Ascorbic acid 180.00 y = 8.6905ln(x) + 4.8673 R2 = 0.9845
3.5. Skin Permeation
Penetration studies were conducted using vertical Franz diffusion cells to compare the
transportation properties of FDNLC and unencapsulated FD extract. Good transport properties
in any delivery system are crucial to transfer the active ingredients into the targeted area. In this
study, the Strat-M™ (Merck Millipore, Billerica, MA, USA) membrane was used as the skin model.
This membrane is composed of multiple layers of polyester sulfone, which could be used as an
alternative to animal or human skin in permeation studies. The skin permeation study was performed
for 24 h. The in vitro release study of the developed NLC and FD extract are portrayed in Figure 7.
The results evidenced a first-order kinetic as the drug is delivered at a rate proportional to the
concentration gradient driving the transfer of drug movement. A study by Patel et al. found that
in vitro release of the active ingredient from the NLC dispersion is biphasic, with the initial burst effect
followed by gradual release of the active ingredient [35]. The results showed a similar trend with the
FDNLC. The initial burst release might be due to the presence of unentrapped FD in the NLC dispersion.
Burst release can be useful to improve the penetration of the active ingredient, while sustained-release
supplies the drug over a prolonged period of time. Non-encapsulated FD extract with the same
concentration of the encapsulated extract was applied for skin diffusion study to compare the transport
properties of encapsulated and non-encapsulated FD water extract. Total phenolic content (TPC)
assay, expressed in gallic acid equivalent (GAE)/g dried extract unit, was utilized to determine FD
in the collected samples for diffusion study. The vitexin in FD extract in the diffusion samples were
undetectable using HPLC because the amount of vitexin was very small. The TPC assay substituted the
HPLC method to quantify the FD extract in the diffusion samples instead. The permeation parameters
calculated from slopes of permeation profiles are listed in Table 3. Steady-state flux, J is the amount
of permeant crossing the skin at a constant rate into the circulating system per unit area. It can be
seen from the graph, that the slope of the FDNLC was steeper than the FD extract. FDNLC had
higher flux, which was 12.73 mg/cm2/h compared to the FD extract, which was only 7.10 mg/cm2/h.
Higher flux indicates a better skin penetration. Permeability coefficient, Kp indicates the rate of
permeant penetration per unit concentration expressed in distance/time. Kp for FDNLC was 0.098 cm/h
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while for FD extract was only 0.04 cm/h. The lag phase of FDNLC was only 0.023 h while for FD
extract was 0.223 h. FDNLC showed rapid penetration through the skin with a very short lag period
after application, indicating that steady-state permeation was reached quickly. This is because the
hydrophilic FD extract had already been encapsulated in the lipid-based carrier. Lag phase increase
for the FD extract. This might be due to the hydrophilic nature of the FD extract. This property of
FD extract will cause it to face difficulties in penetrating the intercellular part of the stratum corneum
because of the difference in polarity.
Cosmetics 2020, 7, x FOR PEER REVIEW 11 of 15 
3.5. Skin Permeation 
Penetration studies were conducted using vertical Franz diffusion cells to compare the 
transportation properties of FDNLC and unencapsulated FD extract. Good transport properties in 
any delivery system are crucial to transfer the active ingredients into the targeted area. In this study, 
the Strat-M™ (Merck Millipore, Billerica, MA, USA) membrane was used as the skin model. This 
membrane is composed of multiple layers of polyester sulfone, which could be used as an alternative 
to animal or human skin in permeation studies. The skin permeation study was performed for 24 h. 
The in vitro release study of the developed NLC and FD extract are portrayed in Figure 7. The results 
evidenced a first-order kinetic as the drug is delivered at a rate proportional to the concentration 
gradient driving the transfer of drug movement. A study by Patel et al. found that in vitro release of 
the active ingredient from the NLC dispersion is biphasic, with the initial burst effect followed by 
gradual release of the active ingredient [35]. The results showed a similar trend with the FDNLC. The 
initial burst release might be due to the presence of unentrapped FD in the NLC dispersion. Burst 
release can be useful to improve the penetration of the active ingredient, while sustained-release 
supplies the drug over a prolonged period of time. Non-encapsulated FD extract with the same 
concentration of the encapsulated extract was applied for skin diffusion study to compare the 
transport properties of encapsulated and non-encapsulated FD water extract. Total phenolic content 
(TPC) assay, expressed in gallic acid equivalent (GAE)/g dried extract unit, was utilized to determine 
FD in the collected samples for diffusion study. The vitexin in FD extract in the diffusion samples 
were undetectable using HPLC because the amount of vitexin was very small. The TPC assay 
substituted the HPLC method to quantify the FD extract in the diffusion samples instead. The 
permeation parameters calculated from slopes of permeation profiles are listed in Table 3. Steady-
state flux, J is the amount of permeant crossing the skin at a constant rate into the circulating system 
per unit area. It can be seen from the graph, that the slope of the FDNLC was steeper than the FD 
extract. FDNLC had higher flux, which was 12.73 mg/cm2/h compared to the FD extract, which was 
only 7.10 mg/cm2/h. Higher flux indicates a better skin penetration. Permeability coefficient, Kp 
indicates the rate of permeant penetration per unit concentration expressed in distance/time. Kp for 
FDNLC was 0.098 cm/h while for FD extract was only 0.04 cm/h. The lag phase of FDNLC was only 
0.023 h while for FD extract was 0.223 h. FDNLC showed rapid penetration through the skin with a 
very short lag period after application, indicating that steady-state permeation was reached quickly. 
This is bec use the hydrophilic FD xtract had already been encapsulat d in the lipid-based carri r. 
Lag phase increase f r the FD extract. This might be due to the hydrophilic nature of the FD extract. 
This property of FD extract will cause it to face difficulties in penetrating the intercellular part of the 



























Figure 7. Cumulative amount of FD permeated for 24 h using Strat-M as the membrane.
Table 3. Permeation parameters for FDNLC and FD extract for the penetration study using Strat-M as
the membrane.
Samples J (mg/cm/h) Kp (cm/h) Tl (hrs)
FDNLC 12.727 9.8 × 10−2 0.023
Unencapsulated FD extract 7.1004 4 × 10−2 0.223
3.6. Cell Proliferative Assay
The MTT (3-[4–dimethylthiazol-2-yl]-2, 5 diphenyl tetrazolium bromide) assay is based on the
conversion of MTT into formazan crystals by living cells, which determines their mitochondrial activity.
Since, for most cell populations, the total mitochondrial activity correlates to the number of viable
cells, this assay is widely utilized to measure the in vitro cytotoxic effects of active compounds on cell
lines or primary patient cells. For this study, the result in Figure 8 revealed that both FDNLC and FD
extract increased cell growth of the human skin fibroblast (HSF) cell lines. For the normal HSF cell,
the cell viability increased with increasing concentration of FDNLC and FD extract. The highest peak
was at 100 µg/mL of FDNLC, which demonstrated viability at 150% ± 0.4%. At 50 and 100 µg/mL,
the cell viability in the occurrence of the FD extract was significantly lower than the cell viability
in FDNLC. Figure 8 shows that cell viability increased when the concentration of FD extract was
higher. This shows that the compounds in FD are capable of proliferating the normal skin cell. This is
supported by the study by Abdulla et al. [4], which shows enhancement in wound healing in rats.
The rats treated with FD also showed decreased scar width, more fibroblast proliferation and more
collagen fibers accompanied by angiogenesis in the granulation tissue. This might be due to the
antioxidant activity and also the phenolic content in the FD itself. However, cell viability was higher in
NLC as seen in Figure 8. This might be because NLC has other components such as virgin coconut oil,
which also could help in proliferating of the cell, and also NLC is said to increase the efficiency of the
active ingredients, which in this study was FD.
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indicate a statistically significant value.
UV irradiation is one of the biggest threats to the skin barrier function to perform well.
Thus, the HSF cell was treated with induced UVB before treated with FDNLC to prove FDNLC
could potentially treat UV irradiation. As for the induced UV irradiation experiment, Figure 9
displays that the cell viability decreased to about 72% ± 1.2% after being treated with UV irradiation.
After treated with ascorbic acid as a positive control, cell viability increased to 76% ± 2.0%. It can
also be seen, when the cell was treated with 12.5 µg/mL of FDNLC, the cell viability increased almost
similar to when it was treated with ascorbic acid. With 50 µg/mL of FDNLC, cell viability also
increased compared to UV treated cells. When using a high concentration of FD extract, cell viability
also increased. This concludes that the damage caused by UV irradiation on fibroblast cells can be
potentially treated using FDNLC, due to the components such as antioxidant and total phenolic content
in the FDNLC that could promote fibroblast cell proliferation. In Figure 9, for the cell viability with
treatment of the FD extract (after 12.5 µg/mL), UV irradiation was only 45% and might be because the
concentration was not enough to treat the UV induced cell. The UV irradiated cell was an abnormal cell,
which might be harder to treat with a low concentration of FD extract only. A study by [36] has shown
the aqueous extracts of four varieties of FD were not toxic within the tested concentration range from 1
to 1 mg/mL. However, it is not totally denied that the FD extract might have its own toxicity.
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Figure 9. The effect of FDNLC on cell viability of fibroblast cells (HSF 1184) after UVB (ultraviolet B)
irradiation (15.0 mJ/cm2, 320 nm). Data are presented as mean ± SD (n = 3). Ascorbic acid, 10—ascorbic
acid at 10µg/mL concentration. * p < 0.05 as compared to FDNLC, indicate a statistically significant value.
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4. Conclusions
For the formulation of the nanostructured lipid carrier loaded with Ficus deltoidea extract (FDNLC)
with the desired particle size, the polydispersity index (PDI) was successfully obtained. The study
showed encapsulation efficiency and active ingredient loading capacity for FDNLC was 87.4% ± 1.3%
and 8.5% ± 1.2%, respectively, and was stable for at least 40 days. Antioxidant activity of FDNLC
was highest when compared to Ficus deltoidea extract and standards. Results from cell cytotoxicity
study proved that FDNLC was not toxic to normal skin cells, and damage by Ultraviolet B (UVB)
irradiation could potentially be treated by FDNLC. Taking the findings from the study, FDNLC could
be a potential topical treatment for skin issues. Further research on the FDNLC ability on treating skin
issues should be done to support this study.
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manuscript, N.A.N.A.; writing—review and editing, R.H., A.A.M.E. and H.M.S.; supervision, R.H.; project
administration, F.D.A.; funding acquisition, R.H. All authors have read and agreed to the published version of
the manuscript.
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